Ajinomoto Bio-Pharma Services

Company Deals

Ajinomoto and Amphastar Ink Licensing Pact for Oncology and wAMD Drug Candidates

Fineline Cube Aug 18, 2025

Nanjing Ajinomoto Bio-Pharma Services and Amphastar Pharmaceuticals (NASDAQ: AMPH) announced on August 12, 2025, the...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod